|
About Validus Pharmaceuticals, Inc.
Validus
Pharmaceuticals is a portfolio investment of Konanda Pharma Fund
I. L.P. which is managed by Konanda Pharma Partners, a private
equity fund focused on acquiring branded specialty pharma
products.
Validus is focused on acquiring, reformulating and
marketing prescription products relevant to the psychiatry and
neurology markets. Validus seeks to acquire mature products
that have well defined and accepted clinical utility relevant to
today’s practice of medicine.
Validus’ portfolio currently includes
Marplan®, which is indicated for the treatment of depression.
Marplan is a member of the monoamine oxidase inhibitor class of
antidepressants.
Please click below
for more information about Marplan®
or Equetro |
CONTACT US
Customer Care Center
866-9VALIDUS
info@validuspharma.com
Headquarters
Validus Pharmaceuticals, Inc.
2001 Route 46 East, Suite 310
Parsippany, NJ 07054
James R. Hunter
President & CEO
Phone: 973-402-4938
Fax: 973-402-4939
jhunter@validuspharma.com
Joseph Lazarich
Chief Marketing Officer
Phone: 973-402-4937
Fax: 973-402-4939
jlazarich@validuspharma.com
|